...
首页> 外文期刊>Glycoconjugate journal >Changes in the glycolipid composition and characteristic activation of GM3 synthase in the thymus of mouse after administration of dexamethasone
【24h】

Changes in the glycolipid composition and characteristic activation of GM3 synthase in the thymus of mouse after administration of dexamethasone

机译:地塞米松给药后小鼠胸腺糖脂成分的变化和GM3合酶的特征性激活

获取原文
获取原文并翻译 | 示例
           

摘要

Glycolipids in the thymus of mice after administration of dexamethasone were compared with those in control mice. In parallel with a decrease in the tissue weight due to the disappearance of immature thymocytes in the cortex, the amounts of GlcCer, Gg(4)Cer and GM1 decreased from 18 h after intraperitoneal administration of dexamethasone, but those of Gb(4)Cer and Forssman glycolipid did not change, indicating the differential distribution of ganglio- and globo-series glycolipids in the thymus, GlcCer, Gg(4)Cer and GM1 being on dexamethasone-sensitive cortical thymocytes, and Gb(4)Cer and Forssman glycolipid on dexamethasone-resistant cells including thymic stromal cells, respectively. At the same time, a characteristic increase in GM3, whose amount per thymus and concentration per mg of thymus were increased 4-fold and 13-fold compared to those in the control mice, respectively, was observed at the onset of the decrease in tissue weight and was due to the increased activity of LacCer sialyltransferase with the enhanced expression of its gene and the concomitant decrease in cytosolic sialidase activity. One can suggest that endogenous accumulation of GM3 is involved in the dexamethasone-induced apoptosis of cortical thymocytes. On radiolabeling of the thymus with CMP-[C-14]-NeuAc, the incorporation of radioactivity into GM3 was preferentially observed in the thymuses of dexamethasone-ad ministered mice, but not in those of control mice, suggesting the possible involvement of plasma membrane-associated sialytransferase in GM3 synthesis in the thymuses of dexamethasone-administered mice.
机译:将地塞米松给药后小鼠胸腺中的糖脂与对照小鼠中的糖脂进行了比较。与皮层中未成熟胸腺细胞消失引起的组织重量减少同时,地塞米松腹膜内给药后18 h,GlcCer,Gg(4)Cer和GM1的量减少,而Gb(4)Cer的量减少而Forssman糖脂没有变化,表明在胸腺中神经节和球蛋白系列糖脂的分布不同,GlcCer,Gg(4)Cer和GM1在地塞米松敏感的皮质胸腺细胞上,而Gb(4)Cer和Forssman糖脂在地塞米松耐药细胞包括胸腺基质细胞。同时,在组织减少开始时,观察到GM3的特征性增加,每只胸腺的量和每毫克胸腺的浓度分别比对照小鼠增加了4倍和13倍。体重增加是由于LacCer唾液酸转移酶活性增加,其基因表达增强,以及胞浆唾液酸酶活性降低。一个可能表明,GM3的内源性积累与地塞米松诱导的皮质胸腺细胞凋亡有关。在用CMP- [C-14] -NeuAc放射性标记胸腺后,在地塞米松治疗的小鼠的胸腺中优先观察到了放射性掺入GM3中,而在对照小鼠的胸腺中则没有观察到这提示可能存在质膜地塞米松小鼠胸腺中GM3合成中的唾液酸相关的唾液酸转移酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号